These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23072449)

  • 21. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
    Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
    Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine.
    Lorenz R; Helmer P; Uedelhoven W; Zimmer B; Weber PC
    Prostaglandins; 1989 Aug; 38(2):157-70. PubMed ID: 2772221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
    Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paired analysis of urinary thromboxane B2 metabolites in humans.
    Catella F; FitzGerald GA
    Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production.
    Westlund P; Kumlin M; Nordenström A; Granström E
    Prostaglandins; 1986 Mar; 31(3):413-43. PubMed ID: 3520685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
    Eikelboom JW; Hankey GJ; Thom J; Bhatt DL; Steg PG; Montalescot G; Johnston SC; Steinhubl SR; Mak KH; Easton JD; Hamm C; Hu T; Fox KA; Topol EJ;
    Circulation; 2008 Oct; 118(17):1705-12. PubMed ID: 18838564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of platelet activation in Alzheimer's disease.
    Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
    Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
    Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
    Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation in patients with colorectal cancer.
    Sciulli MG; Filabozzi P; Tacconelli S; Padovano R; Ricciotti E; Capone ML; Grana M; Carnevale V; Patrignani P
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):79-83. PubMed ID: 15626589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS; Lui SM; Chen CM; Chang WC
    J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry.
    Morrow JD; Minton TA
    J Chromatogr; 1993 Feb; 612(2):179-85. PubMed ID: 8468374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
    Ciabattoni G; Pugliese F; Davi G; Pierucci A; Simonetti BM; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):66-70. PubMed ID: 2752040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary 11-dehydro-thromboxane B₂ and 2,3-dinor-6-keto-prostaglandin-F₁α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg.
    Hartanto MD; Arieselia Z; Setiabudy R; Setiawati A; Baziad A
    J Thromb Thrombolysis; 2012 Jul; 34(1):79-84. PubMed ID: 22311294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of an NAD(+)-dependent dehydrogenase that catalyzes the oxidation of thromboxane B2 at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2 radioimmunoassay to enzyme assay.
    Wu P; Fritzo M; Tai HH
    Biochim Biophys Acta; 1990 Oct; 1036(1):55-63. PubMed ID: 2223826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease.
    Tuppo EE; Forman LJ; Spur BW; Chan-Ting RE; Chopra A; Cavalieri TA
    Brain Res Bull; 2001 Mar; 54(5):565-8. PubMed ID: 11397549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal anti-thromboxane B2 antibody.
    Reinke M; Brune K
    FEBS Lett; 1988 May; 232(1):46-50. PubMed ID: 3130275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A
    McCarthy NS; Vangjeli C; Surendran P; Treumann A; Rooney C; Ho E; Sever P; Thom S; Hughes AD; Munroe PB; Howard P; Johnson T; Caulfield M; Shields DC; O'Brien E; Fitzgerald DJ; Stanton AV
    Atherosclerosis; 2018 Feb; 269():42-49. PubMed ID: 29258006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain.
    Foegh ML; Zhao Y; Madren L; Rolnick M; Stair TO; Huang KS; Ramwell PW
    J Intern Med; 1994 Feb; 235(2):153-61. PubMed ID: 8308478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment.
    Ikonomidis I; Lekakis J; Vamvakou G; Andreotti F; Nihoyannopoulos P
    Am Heart J; 2005 May; 149(5):832-9. PubMed ID: 15894964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.